Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMPG8MF)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting NF-kappa-B-activating kinase (TBK1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID26293650-Compound-34	DMHXT12	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 4	DM53O9Y	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 10	DM2TF64	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 7	DMMYW2L	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 1	DMYKHQ8	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 7	DMW98RI	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 3	DMOE2FZ	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 9	DM5VRXW	N. A.	N. A.	Patented	[1]
Pyrimidinyl compound 2	DM9TW5O	N. A.	N. A.	Patented	[1]
Aminopyrimidine derivative 8	DML83KW	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
NF-kappa-B-activating kinase (TBK1)	TTH5TC2	TBK1_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96.